This HTML5 document contains 51 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n16http://linked.opendata.cz/resource/drugbank/drug/DB06730/identifier/wikipedia/
n17http://linked.opendata.cz/resource/drugbank/drug/DB06730/identifier/pharmgkb/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/mesh/concept/
n6http://linked.opendata.cz/resource/drugbank/drug/DB06730/identifier/pubchem-compound/
n7http://linked.opendata.cz/resource/drugbank/drug/DB06730/identifier/pubchem-substance/
n14http://bio2rdf.org/drugbank:
n9http://linked.opendata.cz/resource/drugbank/drug/DB06730/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://linked.opendata.cz/ontology/mesh/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n8http://linked.opendata.cz/resource/drugbank/drug/DB06730/identifier/chemspider/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB06730
rdf:type
n3:Drug
n3:description
Gestodene is a progestogen hormonal contraceptive. Products containing gestoden include Meliane, which contains 20 mcg of ethinylestradiol and 75 mcg of gestodene; and Gynera, which contains 30 mcg of ethinylestradiol and 75 mcg of gestodene.
n3:group
approved
n3:halfLife
16 to 18 hrs.
owl:sameAs
n13:DB06730 n14:DB06730
dcterms:title
Gestodene
adms:identifier
n6:3033968 n7:99443276 n8:2298532 n9:DB06730 n16:Gestodene n17:PA165958397
n3:synonym
Gestodene SID144205785 Gestoden SH b 331 Gestodeno Gestodenum
n3:synthesisReference
Rino Prendin, Silvio Pirovano, "Process for the preparation of gestodene." U.S. Patent US5719300, issued March, 1994.
n10:hasConcept
n11:M0103314
n3:IUPAC-Name
n4:271B5213-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5219-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5218-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5215-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5216-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5217-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5211-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5212-363D-11E5-9242-09173F13E4C5 n4:271B520F-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5210-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B521F-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5220-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B521A-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B521B-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B521D-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B521C-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B521E-363D-11E5-9242-09173F13E4C5
n3:absorption
in vitro 99% using 3H=R5020 / in vivo similar to progesterone
n3:casRegistryNumber
60282-87-3
n3:category
n3:Bioavailability
n4:271B5225-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5227-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5228-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B5229-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5224-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5223-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5226-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5214-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5221-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5222-363D-11E5-9242-09173F13E4C5